Skip to content

Clinical trials

Phase 2/3 Scleroderma, Systemic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Scleroderma, Systemic Phase: Phase 2/3 Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20051
20072
20132
20172
20181
20201
20222
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Unknown status4
Recruiting3
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Università Politecnica delle Marche2
Actelion1
Assistance Publique - Hôpitaux de Paris1
Cabaletta Bio1
GlaxoSmithKline1
IRCCS San Raffaele1
MediQuest Therapeutics1
National Institute of Allergy and Infectious Diseases (NIAID)1
Northwestern University1
Paul R Fortin1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Scleroderma, Systemic15
Scleroderma, Diffuse8
Autoimmune Diseases4
Pulmonary Fibrosis3
Lung Diseases, Interstitial2
Raynaud Disease2
Arthritis1
Arthritis, Rheumatoid1
Collagen Diseases1
Lupus Erythematosus, Systemic1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.